Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.3%

1 terminated out of 16 trials

Success Rate

92.3%

+5.8% vs benchmark

Late-Stage Pipeline

6%

1 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed with results

Key Signals

92% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (6)
P 3 (1)

Trial Status

Completed12
Recruiting1
Not Yet Recruiting1
Unknown1
Terminated1

Trial Success Rate

92.3%

Benchmark: 86.5%

Based on 12 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
Showing all 16 trials

Research Network

Activity Timeline